Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury

Scandinavian Journal of Urology and Nephrology

Volumn 43, Issue 5, 2009, Pages 390-399

  Shi, Yujun ^a   Tu, Zhidan ^a   Bao, Ji ^a   Sun, Huaiqiang ^a   Wang, We ^a   Luo, Guangheng ^b   Li, Shengfu ^a   Li, Youping ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Interstitial fibrosis; Rat; Renal transplantation; Tubular atrophy; Tubular epithelial cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CYCLOSPORIN A; MESSENGER RNA; OLIGONUCLEOTIDE; UVOMORULIN;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; ATROPHY; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETERIORATION; DISEASE SEVERITY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FISCHER 344 RAT; GENE EXPRESSION; GENE LOCATION; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CONCENTRATING CAPACITY; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY PARENCHYMA; KIDNEY TUBULE; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE EPITHELIUM; LEWIS RAT; MALE; MORPHOLOGICAL TRAIT; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIMED IN SITU LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; GENE EXPRESSION; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; RATS; RATS, INBRED F344; RATS, INBRED LEW; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 70450192742     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365520903142244     Document Type: Article

References (36)

1. Zaltzman JS, Boucher A, Busque S, Halloran PF, Landsberg DN, McAlister VC, et al. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients. Clin Transplant 2005;/19:/26-32.
2. Grinyo JM, Cruzado JM. Mycophenolate mofetil and sirolimus combination in renal transplantation. Am J Transplant 2006;/6:/1991-9.
3. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006;/81:/643-54.
4. Morales JM. Immunosuppressive treatment and progression of histologic lesions in kidney allografts. Kidney Int Suppl 2005;/99:/S124-30.
5. Banasik M, Klinger M. Chronic allograft nephropathy- immunologic and nonimmunologic factors. Ann Transplant 2006;/11:/7-10.
6. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005;/16:/3015-26.
7. Joosten SA, Sijpkens YW, van Kooten C, Paul LC. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005;/68:/1-13.
8. Freese P, Svalander CT, Molne J, Norden G, Nyberg G. Chronic allograft nephropathy - biopsy findings and outcome. Nephrol Dial Transplant 2001;/16:/2401-6.
9. Moreso F, Ibernon M, Goma M, Carrera M, Fulladosa X, Hueso M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006;/6:/747-52.
10. Chapman JR. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Kidney Int Suppl 2005;/99:/S108-12.
11. Legendre C, Thervet E, Skhiri H, Mamzer-Bruneel MF, Cantarovich F, Noel LH, et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998;/65:/1506-9.
12. Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006;/ 6:/2292-306.
13. Lessan-Pezeshki M, Amirzargar A, Fathi A, Khatami MR, Einollahi B, Pourfarziani V, et al. Value of pretransplantation cytokine profiles for predicting acute rejection in renal transplant recipients. Transplant Proc 2005;/37:/2982-4.
14. Sezer S, Akcay A, Ozdemir FN, Kulah E, Arat Z, Haberal M. Post-transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clin Transplant 2004;/18:/ 722-725
15. Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, Sanz- Guajardo A, Palomar-Fontanet R, Arias M. Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004;/19(Suppl 3:iii):/47-51.
16. Shi Y, Wang W, Tu Z, Zhang L, Qiu J, Li Q, et al. The Cterminal peptide of connective tissue growth factor blocks the full molecule binding to tubular epithelial cell. Transplant Proc 2006;/38:/2187-9. (Pubitemid 46068506)
17. Inkinen K, Soots A, Krogerus L, Loginov R, Bruggeman C, Lautenschlager I. Cytomegalovirus enhances expression of growth factors during the development of chronic allograft nephropathy in rats. Transpl Int 2005;/18:/743-9.
18. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end productinduced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006;/ 17:/2484-94.
19. Forino M, Torregrossa R, Ceol M, Murer L, Vella MD, Prete DD, et al. TGFb1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 2006;/87:/197-208.
20. Kiss E, Adams J, Grone HJ, Wagner J. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 2003;/76:/480-9.
21. Kamada N. A description of cuff techniques for renal transplantation in the rat. Use in studies of tolerance induction during combined liver grafting. Transplantation 1985;/39:/93-5.
22. Solez K, Benediktsson H, Cavallo T, Croker B, Demetris AJ, Drachenberg C, et al. Report of The Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 1996;/28:/441-4.
23. White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA. Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 2005;/16:/ 3763-3770
24. Koch J. Primed in situ labeling. Methods Mol Biol 2002;/ 204:/77-84.
25. Coullin P, Roy L, Pellestor F, Candelier JJ, Bed-Hom B, Guillier-Gencik Z, et al. PRINS, the other in situ DNA labeling method useful in cellular biology. Am J Med Genet 2002;/107:/127-35.
26. Wachtel SS, Tharapel AT. FISH and PRINS: competing or complementary technologies? Am J Med Genet 2002;/107:/ 97-98
27. Li H, McGuire TC, Muller-Doblies UU, Crawford TB. A simpler, more sensitive competitive inhibition enzymelinked immunosorbent assay for detection of antibody to malignant catarrhal fever viruses. J Vet Diagn Invest 2001;/ 13:/361-4.
28. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003;/81:/355-63.
29. Leask A, Abraham DJ. TGF-b signaling and the fibrotic response. FASEB J 2004;/18:/816-27.
30. Leask A. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathologic fibrosis. Keio J Med 2004;/53:/ 74-77
31. Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, Gilbert RE, et al. Integrated actions of transforming growth factor-b1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol 2005;/288:/F800-9.
32. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;/69:/213-7. (Pubitemid 43323069)
33. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002;/62:/137-46.
34. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004;/82:/175-81.
35. Badid C, Desmouliere A, Babici D, Hadj-Aissa A, McGregor B, Lefrancois N, et al. Interstitial expression of alpha- SMA: An early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant 2002;/17:/1993-8.
36. Patel S, Mason RM, Suzuki J, Imaizumi A, Kamimura T, Zhang Z. Inhibitory effect of statins on renal epithelial-tomesenchymal transition. Am J Nephrol 2006;/26:/381-7.